Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DnaJ heat shock protein family (Hsp40) member C30 (DNAJC30)
- Target
- DNAJC30
- Molecular classification
- Protein chaperone, Mitochondrial protein, Member of the DNAJ molecular chaperone (Hsp40) family
01
Overview
DnaJ heat shock protein family (Hsp40) member C30 (DNAJC30) is a mitochondrial protein that functions as a chaperone, facilitating the maintenance and turnover of mitochondrial complex I subunits, especially under conditions of oxidative stress. DNAJC30 modulates mitochondrial ATP synthesis and is especially enriched in neuronal tissues, impacting brain development. The gene encoding DNAJC30 is typically deleted in Williams-Beuren syndrome, contributing to the complex phenotype of this neurodevelopmental disorder, and variants are also linked to hereditary optic neuropathies. DNAJC30 acts within a family of molecular chaperones (Hsp40), but its exact biochemical and therapeutic targeting profile remains incompletely characterized.
- Other names
- DNAJC30WBSCR18Williams Beuren syndrome chromosome region 18 proteinMC1DN38LHONAR
02
Mechanism of action
Not applicable, since specific drug mechanisms targeting DNAJC30 are not yet described in the literature
03
Biological functions
Regulation of mitochondrial respiration/ATP synthesisChaperone activity, especially in turnover/degradation of mitochondrial complex I subunits damaged by oxidative stressBrain development
04
Disease associations
Williams-Beuren syndrome (gene deletion linked to syndrome features)Leber hereditary optic neuropathy (modifier)Leber-like hereditary optic neuropathy, autosomal recessive 1Neurodevelopmental disorder
05
Safety considerations
Functional loss contributes to multisystem developmental disorders (e.g., Williams-Beuren syndrome); any therapeutic targeting would need careful monitoring for cognitive, cardiovascular, and metabolic side effects
06
Interacting drugs
None reported in current sources; no direct drug interactions documented as of this search
07
Biomarkers
Deletion/mutation of *DNAJC30* may serve as biomarker for Williams-Beuren syndrome or related optic neuropathies
Beyond the preview
Go deeper on DnaJ heat shock protein family (Hsp40) member C30 (DNAJC30).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DnaJ heat shock protein family (Hsp40) member C30 (DNAJC30).